The present invention relates to a synthetic peptide comprising the following elements from the N-terminus to the C-terminus: a) a first cell-penetrating peptide or functional fragments or derivatives, or biologically active variants thereof and b) a second peptide with agonist activity of OR1 and OR2 receptors or functional fragments or derivatives, or biologically active variants thereof.
Alessandro Silvani, Giuseppe Plazzi, Giorgio Medici, Stefania Trazzi, Elisabetta Ciani, Gabriele Matteoli, et al. (2022). Artificial protein and its applications.
Artificial protein and its applications
Alessandro Silvani;Giuseppe Plazzi;Giorgio Medici;Stefania Trazzi;Elisabetta Ciani;Gabriele Matteoli;Sara Alvente;Viviana Lo Martire;Stefano Bastianini;Chiara Berteotti;Giovanna Zoccoli
2022
Abstract
The present invention relates to a synthetic peptide comprising the following elements from the N-terminus to the C-terminus: a) a first cell-penetrating peptide or functional fragments or derivatives, or biologically active variants thereof and b) a second peptide with agonist activity of OR1 and OR2 receptors or functional fragments or derivatives, or biologically active variants thereof.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
